Department of Molecular Genetics and Microbiology, Cancer Research and Treatment Center, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131,1 Toxicology Program, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131,2 Radiation Oncology Research Laboratory and Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 212013
Received 14 March 2006/ Returned for modification 28 April 2006/ Accepted 2 June 2006
| ABSTRACT |
|---|
|
|
|---|
5-fold enhancement of delayed hyperrecombination (DHR) among cells surviving a low dose of UV-C (5 J/m2), revealed as mixed GFP+/ colonies. UV-B did not induce DHR at an equitoxic (75 J/m2) dose or a higher dose (150 J/m2). UV is known to induce delayed hypermutation associated with increased oxidative stress. We found that hypoxanthine phosphoribosyltransferase (HPRT) mutation frequencies were
5-fold higher in strains derived from GFP+/ (DHR) colonies than in strains in which recombination was directly induced by UV (GFP+ colonies). To determine whether hypermutation was directly caused by hyperrecombination, we analyzed hprt mutation spectra. Large-scale alterations reflecting large deletions and insertions were observed in 25% of GFP+ strains, and most mutants had a single change in HPRT. In striking contrast, all mutations arising in the hypermutable GFP+/ strains were small (1- to 2-base) changes, including substitutions, deletions, and insertions (reminiscent of mutagenesis from oxidative damage), and the majority were compound, with an average of four hprt mutations per mutant. The absence of large hprt deletions in DHR strains indicates that DHR does not cause hypermutation. We propose that UV-induced DHR and hypermutation result from a common source, namely, increased oxidative stress. These two forms of delayed genome instability may collaborate in skin cancer initiation and progression. | INTRODUCTION |
|---|
|
|
|---|
UV induces mutations that can be detected soon after exposure. This direct mutagenesis results from errors during DNA repair or translesion synthesis. UV and other genotoxins, such as ethyl methane sulfonate, also induce mutations many generations after the initial exposure. These delayed mutations arise in a significant fraction (>10%) of exposed cells and reflect a hypermutation phenotype triggered by the original exposure (16, 18, 61, 62). In one study, delayed hypermutation was observed after exposure to UV-A, UV-B, and ionizing radiation (IR) (16). While there is a great deal of information about the spectrum of mutations directly induced by UV (56), only one study compared mutation spectra of early and delayed mutations, and this was limited to a multiplex PCR approach that distinguishes partial and total gene deletions from small-scale changes, such as single-base changes and small deletions/insertions (18). This analysis revealed that nearly 25% of delayed mutations were large deletions and insertions, but large-scale changes were not detected among directly induced mutations.
IR induces DSBs as well as a complex array of direct or indirect DNA adducts, including base damage, single-strand breaks, and DNA-protein cross-links (69). IR can directly induce mutations (40), chromosomal aberrations (14), and homologous recombination (4, 10). IR also induces delayed mutations (16) as well as several other forms of delayed genomic instability, including chromosome aberrations, micronuclei, microsatellite instability, and low viability (47, 49, 50). It was recently shown that IR induces delayed hyperrecombination (DHR); this is a distinct type of genomic instability, as cells expressing the DHR phenotype do not show chromosomal instability or low viability (33). Thus, IR induces at least two mechanistically distinct types of delayed genomic instability.
Although HR is often characterized as an accurate DNA repair pathway, unregulated HR is associated with genome instability. Thus, the hyperrecombination phenotype of cells with defects in RecQ helicases (e.g., human BLM and Saccharomyces cerevisiae Sgs1) is associated with genome instability and cancer predisposition in humans and mice (31, 32, 51). The most conservative HR outcome is gene conversion without an associated crossover, but this still results in localized loss of heterozygosity. HR events associated with crossovers can have more-serious genetic consequences, including large-scale loss of heterozygosity extending from the crossover point to the telomere as well as deletions, inversions, and translocations (53).
Given that IR and UV radiation each induce multiple forms of DNA damage and delayed genomic instability, we have tested the hypothesis that UV induces DHR and that DHR is associated with hypermutation. We exposed human colorectal carcinoma cells carrying a green fluorescent protein (GFP)-based HR substrate to various doses of UV-B or UV-C. In this system, direct induction of HR produces homogenous GFP+ colonies, whereas DHR produces mixed GFP+/ colonies. We show that UV-C, but not UV-B, induces DHR in up to 15% of surviving cells. Interestingly, mutation frequencies in DHR strains, measured at the HPRT locus, were
5-fold higher than in non-DHR cells (GFP+) isolated from the same UV-irradiated population that gave rise to DHR cells. The mutation spectrum indicated that hypermutation is not caused by HR but showed evidence of arising from oxidative DNA damage. Oxidative damage also stimulates HR, suggesting a model in which UV-induced DHR and hypermutation are independent forms of delayed genome instability resulting from a common stressor, increased oxidative DNA damage.
| MATERIALS AND METHODS |
|---|
|
|
|---|
100 colonies and allowed to adhere for at least 3 h. Cells were rinsed twice with phosphate-buffered saline (PBS) and resuspended in PBS during UV exposures. Dishes were uncovered and exposed to UV-C irradiation using the germicidal UV lamp in a tissue culture hood and to UV-B using a UV-B lamp (UV Products, Upland, CA). Doses of UV-B and UV-C were determined with a UVX radiometer (UV Products). Emission spectra of the light sources were obtained using a calibrated Optronics 742 scanning spectroradiometer (Optronic Laboratories, Orlando, FL). After exposure, fresh growth medium was added and cultures were incubated for 10 to 14 days. To measure cell survival after UV treatment, colonies were stained with crystal violet in methanol, and those with at least 50 cells were scored. Delayed hyperrecombination assay. To measure DHR, 10- to 14-day-old colonies treated as described above were washed twice with PBS. Green fluorescent cells were detected with an inverted Nikon TE2000 microscope powered by an argon laser (488 nm), and images were captured by using LaserSharp 2000 confocal software using a fluorescein isothiocyanate filter (Bio-Rad, Hercules, CA). Differential interference contrast images were captured with a transmission filter. For each determination, a total of 90 colonies were analyzed in three dishes. Colonies were scored as GFP+, GFP, or mixed GFP+/. GFP+/ colonies with >4 GFP+ cells in an otherwise GFP colony were scored as DHR, and colonies with >4 GFP cells in an otherwise GFP+ colony were scored as delayed mutation.
Analysis of HPRT mutations. GFP, GFP+, and GFP+/ colonies were expanded, and hypoxanthine phosphoribosyltransferase (HPRT) mutation frequencies were measured as described by Glaab et al. (29). Briefly, preexisting hprt mutants were eliminated from expanded colonies by culturing in HAT selection medium (Dulbecco's modified Eagle's medium with 10% bovine growth serum, 100 µM hypoxanthine, 0.4 µM aminopterin, 16 µM thymidine; Sigma) for at least 14 days. Cells were then seeded into 10-cm dishes at 5 x 104 cells per dish and incubated in fresh growth medium for another 14 days to express the hprt mutant phenotype before being plated at 5 x 104 per dish in selective growth medium containing 30 µM 6-thioguanine (6-TG; Sigma). Cell viability was measured by plating 1,000 cells per dish in nonselective medium, calculated as the ratio of colonies formed to cells plated (plating efficiency). After 14 days, 6-TG-resistant colonies were chosen for expansion and subsequent analysis of mutation spectra; the remaining colonies were stained and counted as described above. Mutation frequencies were calculated as the number of 6-TG-resistant colonies divided by the number of viable cells plated in 6-TG medium. Because hprt mutants were eliminated from initial populations and initial populations were large, mutation frequencies are not strongly affected by "jackpots" and are therefore valid measures of spontaneous events. Mutations in expanded 6-TG-resistant colonies were analyzed by reverse-transcriptase PCR (RT-PCR) essentially as described by Denault et al. (20). Briefly, total RNA was extracted from 6-TG-resistant cells using the RNeasy mini kit (QIAGEN, Valencia, CA). cDNA was produced by reverse transcription using 2 µg RNA in 20-µl reaction mixtures with 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol, 10 mM each of four deoxynucleoside triphosphates, 0.1 µg/liter bovine serum albumin, 2 pmol primer VM2 (5'-GATAATTTTACTGGCGATGT), 40 units/µl RNase inhibitor (Applied Biosystems, Foster City, CA), 2.5% NP-40, and 200 units/µl Moloney murine leukemia virus reverse transcriptase (Invitrogen, Carlsbad, CA). Reaction mixtures were incubated at 37°C for 1 h and stopped by heating to 70°C for 15 min. Two microliters of each cDNA reaction mixture was added to a 50-µl PCR mixture with 20 mM Tris-HCl, pH 8.4, 50 mM KCl, 2.75 mM MgCl2, 400 µM of each deoxynucleoside triphosphate, 0.2 pmol primer VM1 (5'-CTGCTCCGCCACCGGCTTCC), 0.2 pmol of VM2, and 2.5 units Taq Gold polymerase (PerkinElmer, Wellesley, MA). Reaction mixtures were incubated for 35 cycles comprising 1 min at 94°C, 1 min at 50°C, and 2 min at 72°C. A second round of PCR with nested primers was performed by using 1-µl aliquots of the initial PCR in a 50-µl PCR mixture as described above, except that 0.5 ng/µl each of primers VM3 (5'-CCTGAGCAGTCAGCCCGCGC) and VM4 (5'-CAATAGGACTCCAGATGTTT) was used. PCR products were analyzed by agarose gel electrophoresis. PCR products were then sequenced using primers UNC3 (5'-GCCGGCTCCGTTATGGCGAC) and UNC2 (5'-GGTGTTTATTCCTCATGGAC).
Detection of ROS. Microscopic and fluorescence-activated cell sorter analyses of intracellular ROS were performed as described by Shi et al. (59). Briefly, cells were seeded into 10-cm dishes with or without coverslips and grown to 75% confluence. Cells were incubated with 2 µM dihydroethidium (DHE; Sigma) at 37°C for 1 h. Positive controls included 150 µM sodium dichromate dihydrate (Sigma), an oxidizing agent. Cells on coverslips were washed twice with PBS and fixed in 70% ethanol for 30 min, rinsed with PBS, mounted onto slides, and analyzed using a Zeiss Axioskop 40 microscope with Texas Red filter and Picture Frame software. Cells in dishes without coverslips were trypsinized, fixed in 70% ethanol for 30 min, suspended in PBS, and analyzed with a Becton Dickinson FACScan and CellQuest Pro 5.2 software. Gated excitation of DHE-mediated forward scatter was detected at 585 ± 21 nm (mean ± standard deviation), and side scatter was used to detect all cells.
| RESULTS |
|---|
|
|
|---|
GFP+/, predominantly GFP) or delayed mutation (GFP+
GFP+/, predominantly GFP+). In this study, we used the GFP assay to score DHR and a more sensitive hprt mutation assay to score delayed hypermutation (Fig. 1B).
|
|
|
105, consistent with previous reports (23, 41). The average mutation frequency of the GFP+ isolates was severalfold higher, but there was some overlap among individual GFP+ (exposed) and GFP (unexposed) strains. In contrast, all GFP+/ strains showed strong hypermutation phenotypes, with mutation frequencies averaging >100-fold higher than GFP strains and
13-fold higher than GFP+ strains (Fig. 4A). In addition, plating efficiencies of GFP+ and GFP+/ strains were similar, and neither was lower than that of GFP strains (Fig. 4B). These results indicate that UV-C induces DHR that is associated with hypermutation and that these forms of genetic instability do not reduce cell viability.
|
|
|
Transversion mutations are commonly induced by oxidative DNA damage (3, 25, 34, 35, 39). To determine whether DHR-associated hypermutation resulted from persistent oxidative stress, we examined the oxidation states of UV-C-irradiated DHR and non-DHR cells by using the fluorescent probe DHE (59). Microscopic analysis revealed no difference in oxidation state between DHR and non-DHR cells (Fig. 6), nor was a difference apparent by fluorescence-activated cell sorter analysis (data not shown). While these results indicate that persistent oxidative stress is not the underlying cause of UV-C-induced DHR/hypermutation, they do not rule out the possibility that these phenotypes result from time-limited "bursts" of oxidative stress (see Discussion).
|
| DISCUSSION |
|---|
|
|
|---|
20% survival) but not at a lower dose giving 50% survival (Fig. 2 and 3), suggesting a more typical dose response. Nonetheless, the significant cell survival and the high frequency of DHR induction, which approached 15% of cells surviving 5 J/m2 UV-C, suggest that DHR is not due to inactivation of one or a few specific target genes but is more likely an epigenetic effect with a target perhaps as large as the nucleus or the entire cell, as suggested for IR-induced DHR (33). DHR is not induced by acute doses of UV-B (Fig. 3B), but Dahle et al. (18) showed that UV-B does induce delayed hypermutation. Although this might suggest distinct mechanisms for induction of hypermutation by UV-B and UV-C, these results may reflect differences in study design. We measured hprt mutagenesis after screening for DHR, 40 days after UV exposure (Fig. 1B), whereas Dahle et al. (18) detected hprt hypermutation 10 days after UV exposure. In addition, the lack of a DHR response with acute UV-B exposure does not preclude the possibility of DHR induction by chronic UV-B exposure from sunlight. The UV-B and UV-C doses used in the present study required short exposures (several seconds), so repair occurring during the exposure cannot account for the difference in DHR induction. UV-C has higher energy than UV-B, and the more-acute damaging effects of UV-C may explain this difference. Although our analysis of UV-induced DHR focused on a single cell type derived from a human tumor, it is likely to be a general effect because the various forms of delayed genomic instability have been observed in a wide variety of cell types, in animal models, and after exposures to many types of genotoxic agents (13, 16, 22, 24, 30, 52, 60, 64). In addition, the RKO-derived cells we studied express functional p53 (33), so DHR is not restricted to p53-defective cells (i.e., the majority of tumor cells). UV-induced delayed hypermutation has been observed in several studies (16, 18, 61, 62), but only one included an analysis of mutation spectra, and this was limited to agarose gel analysis of PCR-amplified hprt exons (18). In that study, delayed mutations after UV-B exposure showed a higher fraction of large-scale deletions than directly induced mutations; presumably, the directly induced mutations would show a typical "UV-signature," with a high fraction occurring at dipyrimidines and longer pyrimidine runs (7, 66). In the present study, we did not measure directly induced mutations but focused instead on spontaneous mutations arising in DHR or non-DHR cells nearly 6 weeks after UV-C exposure and found that all DHR strains were hypermutable. However, if the enhanced mutability of DHR cells was a direct consequence of HR (i.e., between Alu repeats in hprt introns), one would expect the DHR mutation spectrum to show a significant fraction of exon deletions (28). Instead, all hprt mutations arising in DHR strains were point mutations, defined here as 1-bp or tandem 2-bp substitutions, deletions, and insertions. Thus, while DHR and hypermutation are associated, the extra mutations are not directly caused by HR. Instead, DHR and hypermutation probably result from a common upstream event or cellular state (see below).
Large-scale deletions and insertions, as well as point mutations, were observed in non-DHR cells, consistent with the known spectrum of spontaneous hprt mutations (11). One difference between DHR and non-DHR mutation spectra was the absence of large deletions in the DHR mutants. A study of delayed hprt mutations after IR in Chinese hamster ovary cells showed similar results, with large deletions predominant among directly induced mutants but much less frequent among delayed mutants from IR-treated cells and spontaneous mutants from untreated cells (44). An even more striking difference in the DHR and non-DHR mutation spectra was the much larger fraction of compound point mutations arising in DHR strains. Although compound mutations were observed in non-DHR cells, three of five were associated with kilobase pair deletions and included large insertions or "sequence captures." These are reminiscent of products formed during DSB repair by nonhomologous end joining (2, 43, 45) and may therefore reflect single mutational events, albeit with complex outcomes. That three of the four large deletion mutations were related, but not identical, is further evidence that they reflect different outcomes initiated by a single DSB repair event.
If we consider only point mutations (predominant in both spectra), the frequency of mutants with compound point mutations was fourfold higher in DHR cells than in non-DHR cells (Table 1). In addition, hprt mutants from DHR cells had an average of 4 mutations, and three harbored 5, 6, and 11 mutations, whereas non-DHR cells had at most 2 point mutations. Although the high frequency of compound point mutations in DHR cells is consistent with their hypermutation phenotype, questions arise as to their origin. Specifically, are compound mutations a consequence of linked mutational events, or does each mutation (or cluster of mutations) arise independently? Assuming that these mutations result from misrepair and/or error-prone translesion synthesis at sites of DNA damage, we can envision three different scenarios for compound mutation formation. In the first, DNA damage levels are low, but repair (or translesion) synthesis by an error-prone DNA polymerase initiates at a lesion and produces errors through base misincorporation or base skipping/addition over a long distance (Fig. 7A). However, this is not consistent with the low processivity of repair and translesion DNA polymerases (57). In the second scenario, DNA damage levels are also low, but individual mutations arise sequentially in different cell cycles (Fig. 7B). In this case, one would expect a significant fraction of shared "founder" mutations, but this was not observed. For these reasons, we favor a third model in which DNA damage levels are high in hypermutable cells, with multiple mutations arising independently during a single cell cycle due to multiple misrepair/translesion synthesis events (Fig. 7C). This model is also consistent with the widely dispersed mutations in each compound mutant. Spontaneous compound mutations are quite rare; thus, it is surprising that they appear so frequently in DHR cells. These cells show normal viability (Fig. 4B), suggesting that the genome as a whole is not susceptible to an extreme mutagenic load. Perhaps these cells are suffering from localized "bursts" of damage.
|
|
A), producing a V600
E amino acid substitution that activates the kinase domain and is sufficient to transform NIH 3T3 cells (previously thought to be V599
E) (9, 19). This T
A transversion cannot arise from UV photoproducts but is more consistent with oxidative DNA damage. A strong oxidative damage signature was also seen in N-ras mutations in congenital melanocytic nevi, which have a high probability of transformation into malignant melanoma. More than half of the identified N-ras mutations were in codon 61, and 90% of these resulted from a C
A transversion, a signature oxidative damage mutation. This N-ras mutation is also prevalent in familial melanoma associated with CDKN2 mutations (26, 54). The association of hypermutation and DHR in UV-exposed cells suggests that these forms of genomic instability may collaborate in the initiation and progression of melanoma and other skin cancers.
| ACKNOWLEDGMENTS |
|---|
This work was supported by the Biological and Environmental Research Program (BER), U.S. Department of Energy, grant DE-FG02-01-ER63230, and National Cancer Institute (NIH) grant R01CA73924 to W.F.M., NCI grant R21CA113687 to G.S.T., and NCI grant R01CA77693 to J.A.N.
| FOOTNOTES |
|---|
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Allen, C., C. A. Miller, and J. A. Nickoloff. 2003. The mutagenic potential of a single DNA double-strand break is not influenced by transcription. DNA Repair 2:1147-1156.[CrossRef][Medline]
3. Arai, T., V. P. Kelly, O. Minowa, T. Noda, and S. Nishimura. 2002. High accumulation of oxidative DNA damage, 8-hydroxyguanine, in Mmh/Ogg1 deficient mice by chronic oxidative stress. Carcinogenesis 23:2005-2010.
4. Benjamin, M. B., and J. B. Little. 1992. X rays induce interallelic homologous recombination at the human thymidine kinase gene. Mol. Cell. Biol. 12:2730-2738.
5. Bjelland, S., and E. Seeberg. 2003. Mutagenicity, toxicity and repair of DNA base damage induced by oxidation. Mutat. Res. 531:37-80.[Medline]
6. Boyer, J. C., A. Umar, J. I. Risinger, J. R. Lipford, M. Kane, S. Yin, J. C. Barrett, R. D. Kolodner, and T. A. Kunkel. 1995. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res. 55:6063-6070.
7. Brash, D. E., J. A. Rudolph, J. A. Simon, A. Lin, G. J. McKenna, H. P. Baden, A. J. Halperin, and J. Ponten. 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88:10124-10128.
8. Brenneman, M. A. 2001. BRCA1 and BRCA2 in DNA repair and genome stability, p. 237-267. In J. A. Nickoloff and M. F. Hoekstra (ed.), DNA damage and repair, vol. 3: advances from phage to humans. Humana Press, Totowa, N.J.
9. Brose, M. S., P. Volpe, M. Feldman, M. Kumar, I. Rishi, R. Gerrero, E. Einhorn, M. Herlyn, J. Minna, A. Nicholson, J. A. Roth, S. M. Albelda, H. Davies, C. Cox, G. Brignell, P. Stephens, P. A. Futreal, R. Wooster, M. R. Stratton, and B. L. Weber. 2002. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 62:6997-7000.
10. Cao, J., S. E. DePrimo, and J. R. Stringer. 1997. Cell cycle dependence of radiation-induced homologous recombination in cultured monkey cells. Mutat. Res. 374:233-243.[Medline]
11. Cariello, N. F., and T. R. Skopek. 1993. Analysis of mutations occurring at the human hprt locus. J. Mol. Biol. 231:41-57.[CrossRef][Medline]
12. Chadwick, C. A., C. S. Potten, O. Nikaido, T. Matsunaga, C. Proby, and A. R. Young. 1995. The detection of cyclobutane thymine dimers, (6-4) photolesions and the Dewar photoisomers in sections of UV-irradiated human skin using specific antibodies, and the demonstration of depth penetration effects. J. Photochem. Photobiol. B 28:163-170.[CrossRef][Medline]
13. Coates, P. J., S. A. Lorimore, and E. G. Wright. 2004. Damaging and protective cell signalling in the untargeted effects of ionizing radiation. Mutat. Res. 568:5-20.[Medline]
14. Cornforth, M. N. 1989. On the nature of interactions leading to radiation-induced chromosomal exchange. Int. J. Radiat. Biol. 56:635-643.[Medline]
15. Dahle, J., and E. Kvam. 2004. Increased level of oxidative stress in genomically unstable cell clones. J. Photochem. Photobiol. B 74:23-28.[Medline]
16. Dahle, J., and E. Kvam. 2003. Induction of delayed mutations and chromosomal instability in fibroblasts after UVA-, UVB-, and X-radiation. Cancer Res. 63:1464-1469.
17. Dahle, J., E. Kvam, and T. Stokke. 2005. Bystander effects in UV-induced genomic instability: antioxidants inhibit delayed mutagenesis induced by ultraviolet A and B radiation. J. Carcinog. 4:11.[CrossRef][Medline]
18. Dahle, J., P. Noordhuis, T. Stokke, D. H. Svendsrud, and E. Kvam. 2005. Multiplex polymerase chain reaction analysis of UV-A- and UV-B-induced delayed and early mutations in V79 Chinese hamster cells. Photochem. Photobiol. 81:114-119.[Medline]
19. Davies, H., G. R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, M. J. Garnett, W. Bottomley, N. Davis, E. Dicks, R. Ewing, Y. Floyd, K. Gray, S. Hall, R. Hawes, J. Hughes, V. Kosmidou, A. Menzies, C. Mould, A. Parker, C. Stevens, S. Watt, S. Hooper, R. Wilson, H. Jayatilake, B. A. Gusterson, C. Cooper, J. Shipley, D. Hargrave, K. Pritchard-Jones, N. Maitland, G. Chenevix-Trench, G. J. Riggins, D. D. Bigner, G. Palmieri, A. Cossu, A. Flanagan, A. Nicholson, J. W. Ho, S. Y. Leung, S. T. Yuen, B. L. Weber, H. F. Seigler, T. L. Darrow, H. Paterson, R. Marais, C. J. Marshall, R. Wooster, M. R. Stratton, and P. A. Futreal. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949-954.[CrossRef][Medline]
20. Denault, C. M., T. R. Skopek, and H. L. Liber. 1993. The effects of hypoxia and cysteamine on X-ray mutagenesis in human cells. II. hprt mRNA expression and cDNA sequence analysis of induced mutants. Radiat. Res. 136:271-279.[Medline]
21. Deng, W. P., and J. A. Nickoloff. 1994. Preferential repair of UV damage in highly transcribed DNA diminishes UV-induced intrachromosomal recombination in mammalian cells. Mol. Cell. Biol. 14:391-399.
22. Devi, P. U., and M. Satyamitra. 2005. Tracing radiation induced genomic instability in vivo in the haemopoietic cells from fetus to adult mouse. Br. J. Radiol. 78:928-933.
23. Diaz-Llera, S., A. Podlutsky, A. M. Osterholm, S. M. Hou, and B. Lambert. 2000. Hydrogen peroxide induced mutations at the HPRT locus in primary human T-lymphocytes. Mutat. Res. 469:51-61.[Medline]
24. Dowling, K., C. Seymour, and C. Mothersill. 2005. Delayed cell death and bystander effects in the progeny of Chinook salmon embryo cells exposed to radiation and a range of aquatic pollutants. Int. J. Radiat. Biol. 81:89-96.[CrossRef][Medline]
25. Efrati, E., G. Tocco, R. Eritja, S. H. Wilson, and M. F. Goodman. 1999. "Action-at-a-distance" mutagenesis. 8-Oxo-7, 8-dihydro-2'-deoxyguanosine causes base substitution errors at neighboring template sites when copied by DNA polymerase beta. J. Biol. Chem. 274:15920-15926.
26. Eskandarpour, M., J. Hashemi, L. Kanter, U. Ringborg, A. Platz, and J. Hansson. 2003. Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations. J. Natl. Cancer Inst. 95:790-798.
27. Friedberg, E. C. 2001. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 1:22-33.[CrossRef][Medline]
28. Gebow, D., N. Miselis, and H. L. Liber. 2000. Homologous and nonhomologous recombination resulting in deletion: effects of p53 status, microhomology, and repetitive DNA length and orientation. Mol. Cell. Biol. 20:4028-4035.
29. Glaab, W. E., K. R. Tindall, and T. R. Skopek. 1999. Specificity of mutations induced by methyl methanesulfonate in mismatch repair-deficient human cancer cell lines. Mutat. Res. 427:67-78.[Medline]
30. Glaviano, A., V. Nayak, E. Cabuy, D. M. Baird, Z. Yin, R. Newson, D. Ladon, M. A. Rubio, P. Slijepcevic, F. Lyng, C. Mothersill, and C. P. Case. 2006. Effects of hTERT on metal ion-induced genomic instability. Oncogene 25:3424-3435.[CrossRef][Medline]
31. Goss, K. H., M. A. Risinger, J. J. Kordich, M. M. Sanz, J. E. Straughen, L. E. Slovek, A. J. Capobianco, J. German, G. P. Boivin, and J. Groden. 2002. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297:2051-2053.
32. Hickson, I. D. 2003. RecQ helicases: caretakers of the genome. Nat. Rev. Cancer 3:169-178.[CrossRef][Medline]
33. Huang, L., S. Grim, L. E. Smith, P. M. Kim, J. A. Nickoloff, O. G. Goloubeva, and W. F. Morgan. 2004. Ionizing radiation induces delayed hyperrecombination in mammalian cells. Mol. Cell. Biol. 24:5060-5068.
34. Kino, K., and H. Sugiyama. 2005. UVR-induced G-C to C-G transversions from oxidative DNA damage. Mutat. Res. 571:33-42.[Medline]
35. Klungland, A., I. Rosewell, S. Hollenbach, E. Larsen, G. Daly, B. Epe, E. Seeberg, T. Lindahl, and D. E. Barnes. 1999. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. USA 96:13300-13305.
36. Kolodner, R. D. 1995. Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci. 20:397-401.[CrossRef][Medline]
37. Kvam, E., and R. M. Tyrrell. 1997. Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis 18:2379-2384.
38. Lankinen, M. H., L. M. Vilpo, and J. A. Vilpo. 1996. UV- and gamma-irradiation-induced DNA single-strand breaks and their repair in human blood granulocytes and lymphocytes. Mutat. Res. 352:31-38.[Medline]
39. Larsen, E., K. Reite, G. Nesse, C. Gran, E. Seeberg, and A. Klungland. 2006. Repair and mutagenesis at oxidized DNA lesions in the developing brain of wild-type and Ogg1/ mice. Oncogene 25:2425-2432.[CrossRef][Medline]
40. Liber, H. L., and E. N. Phillips. 1998. Interrelationships between radiation-induced mutations and modifications in gene expression linked to cancer. Crit. Rev. Eukaryot. Gene Expr. 8:257-276.[Medline]
41. Liber, H. L., D. W. Yandell, and J. B. Little. 1989. A comparison of mutation induction at the tk and hprt loci in human lymphoblastoid cells; quantitative differences are due to an additional class of mutations at the autosomal tk locus. Mutat. Res. 216:9-17.[CrossRef][Medline]
42. Limoli, C. L., E. Giedzinski, W. M. Bonner, and J. E. Cleaver. 2002. UV-induced replication arrest in the xeroderma pigmentosum variant leads to DNA double-strand breaks,
-H2AX formation, and Mre11 relocalization. Proc. Natl. Acad. Sci. USA 99:233-238.
43. Lin, Y., and A. S. Waldman. 2001. Capture of DNA sequences at double-strand breaks in mammalian chromosomes. Genetics 158:1665-1674.
44. Little, J. B., H. Nagasawa, T. Pfenning, and H. Vetrovs. 1997. Radiation-induced genomic instability: delayed mutagenic and cytogenetic effects of x-rays and
-particles. Radiat. Res. 148:299-307.[Medline]
45. Little, K. C., and P. Chartrand. 2004. Genomic DNA is captured and amplified during double-strand break (DSB) repair in human cells. Oncogene 23:4166-4172.[CrossRef][Medline]
46. Lutsenko, E. A., J. M. Carcamo, and D. W. Golde. 2002. Vitamin C prevents DNA mutation induced by oxidative stress. J. Biol. Chem. 277:16895-16899.
47. Marder, B. A., and W. F. Morgan. 1993. Delayed chromosomal instability induced by DNA damage. Mol. Cell. Biol. 13:6667-6677.
48. Morgan, W. F. 2003. Is there a common mechanism underlying genomic instability, bystander effects and other nontargeted effects of exposure to ionizing radiation? Oncogene 22:7094-7099.[CrossRef][Medline]
49. Morgan, W. F. 2003. Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat. Res. 159:567-580.[Medline]
50. Morgan, W. F. 2003. Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat. Res. 159:581-596.[CrossRef][Medline]
51. Myung, K., A. Datta, C. Chen, and R. D. Kolodner. 2001. SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination. Nat. Genet. 27:113-116.[CrossRef][Medline]
52. Nagar, S., L. E. Smith, and W. F. Morgan. 2005. Variation in apoptosis profiles in radiation-induced genomically unstable cell lines. Radiat. Res. 163:324-331.[CrossRef][Medline]
53. Nickoloff, J. A. 2002. Recombination: mechanisms and roles in tumorigenesis, p. 49-59. In J. R. Bertino (ed.), Encyclopedia of cancer, 2nd ed., vol. 4. Elsevier Science, San Diego, Calif.
54. Papp, T., H. Pemsel, R. Zimmermann, R. Bastrop, D. G. Weiss, and D. Schiffmann. 1999. Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J. Med. Genet. 36:610-614.
55. Pascucci, B., A. Versteegh, A. van Hoffen, A. A. van Zeeland, L. H. Mullenders, and E. Dogliotti. 1997. DNA repair of UV photoproducts and mutagenesis in human mitochondrial DNA. J. Mol. Biol. 273:417-427.[CrossRef][Medline]
56. Pfeifer, G. P., Y. H. You, and A. Besaratinia. 2005. Mutations induced by ultraviolet light. Mutat. Res. 571:19-31.[Medline]
57. Prakash, S., R. E. Johnson, and L. Prakash. 2005. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu. Rev. Biochem. 74:317-353.[CrossRef][Medline]
58. Sekiguchi, M., and T. Tsuzuki. 2002. Oxidative nucleotide damage: consequences and prevention. Oncogene 21:8895-8904.[CrossRef][Medline]
59. Shi, H., L. G. Hudson, W. Ding, S. Wang, K. L. Cooper, S. Liu, Y. Chen, X. Shi, and K. J. Liu. 2004. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem. Res. Toxicol. 17:871-878.[CrossRef][Medline]
60. Somodi, Z., N. A. Zyuzikov, G. Kashino, K. R. Trott, and K. M. Prise. 2005. Radiation-induced genomic instability in repair deficient mutants of Chinese hamster cells. Int. J. Radiat. Biol. 81:929-936.[CrossRef][Medline]
61. Stamato, T. D., and M. L. Perez. 1998. EMS and UV-light-induced colony sectoring and delayed mutation in Chinese hamster cells. Int. J. Radiat. Biol. 74:739-745.[CrossRef][Medline]
62. Stamato, T. D., E. Richardson, and M. L. Perez. 1995. UV-light induces delayed mutations in Chinese hamster cells. Mutat. Res. 328:175-181.[Medline]
63. Storz, P., H. Doppler, and A. Toker. 2005. Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Mol. Cell. Biol. 25:8520-8530.
64. Suzuki, K., M. Ojima, S. Kodama, and M. Watanabe. 2003. Radiation-induced DNA damage and delayed induced genomic instability. Oncogene 22:6988-6993.[CrossRef][Medline]
65. Tauchi, H., S. Matsuura, J. Kobayashi, S. Sakamoto, and K. Komatsu. 2002. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 58:8967-8980.
66. Tornaletti, S., D. Rozek, and G. P. Pfeifer. 1993. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene 8:2051-2057.[Medline]
67. Tutt, A., D. Bertwistle, J. Valentine, A. Gabriel, S. Swift, G. Ross, C. Griffin, J. Thacker, and A. Ashworth. 2001. Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J. 20:4704-4716.[CrossRef][Medline]
68. Vreeswijk, M. P., A. van Hoffen, B. E. Westland, H. Vrieling, A. A. van Zeeland, and L. H. Mullenders. 1994. Analysis of repair of cyclobutane pyrimidine dimers and pyrimidine 6-4 pyrimidone photoproducts in transcriptionally active and inactive genes in Chinese hamster cells. J. Biol. Chem. 269:31858-31863.
69. Ward, J. 1998. The nature of lesions formed by ionizing radiation, p. 65-84. In J. A. Nickoloff and M. F. Hoekstra (ed.), DNA damage and repair: DNA repair in higher eukaryotes, vol. 2. Humana Press, Totowa, N.J.
70. Winn, L. M., P. M. Kim, and J. A. Nickoloff. 2003. Oxidative stress-induced homologous recombination as a novel mechanism for phenytoin-initiated toxicity. J. Pharmacol. Exp. Ther. 306:523-527.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||